Biotech Values

[biopearl]

General question for the board (read, Dew) Is there any qualitative difference between a company sponsored study vs one sponsored by the NCI? If the NCI is sponsoring a study does that imply some sense that the study is less hopeless (or more hopeful)? What percent of company sponsored trials go from phase II to phase III vs. NCI sponsored trials? Does the company supplying the study drug have ready access to the results or are the results the property of NCI? Is there any insight as to how the NCI selects drugs to test compared to what an individual company might do? Ok I am out of questions for the moment. Thanks for your consideration. Regards, bp